We are Minomic
Company Background
We are based in Sydney, adjacent to one of Australia’s leading universities, Macquarie University, and the Macquarie University Hospital, one of our key collaborators.
Our reach is global, through partnerships with universities, research institutes, and companies.
Our experience is backed up by independent experts in oncology, awards of multiple research grants, a major innovation prize, and investment backing of over A$27 million to date.
Extensive intellectual property
Minomic owns an extensive patent estate protecting our distinctive technology. All the intellectual property relevant to our technology is owned by us.
Our investors and funding support
Minomic is an unlisted public company.
Apart from equity investment, other sources of funding include:
- A grant from the Advanced Manufacturing Growth Centre’s (AMGC) Commercialisation Fund to facilitate the rollout of MiCheck® Prostate in Australia
- an Australian Government Accelerating Commercialisation grant to help validate MiCheck® Prostate and support our rollout;
- Australian Government R&D Tax Incentives;
- a National Health and Medical Research Council Development Grant with QUT;
- ARC Hub award.
Contact us if you are interested in investing in the future of Minomic International.
Get In Touch
More Info
Would you like to talk with Minomic about:
- Partnering with us to take our products to your markets?
- Media or upcoming events?
- Some feedback that you have?
Address
Level 1, 3 Innovation Road, Macquarie Park NSW 2113, Australia
Australian Business Number
14 124 455 081